Abstract
With cell-by-cell mapping, we charted immune cells in lymphocytic-variant hypereosinophilic syndrome, found drug targets, and showed targeted therapy removed disease-causing cells and eased symptoms.
Funding Information
  • Leukemia and Lymphoma Society (1377-21)
  • Bakewell Foundation (N/A)

This publication has 9 references indexed in Scilit: